Plain-English translation of NCT06814444 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that collects blood and bone marrow samples from people diagnosed with acute leukemia. Researchers will study these samples to understand how a patient's immune system and metabolism change with the disease. By comparing samples from leukemia patients with samples from healthy volunteers, the study aims to gain insights that could help develop better treatments.
Doctors need to better understand how the immune system behaves in acute leukemia patients so they can create more effective and personalized treatments. This research may help explain why different patients respond differently to therapy and could lead to improvements in how leukemia is treated.
You likely qualify if…
You likely don't qualify if…
As a participant, you will donate blood and bone marrow samples during your routine medical visits at the hospital — these will be collected as part of your normal care appointments. You may be asked to provide samples at multiple time points during your treatment. The samples will be studied in the laboratory to examine your immune cells and metabolic profiles. The study does not require any special visits or procedures beyond what you would normally receive as part of your leukemia treatment.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Italy
Enrollment target
~170 participants
Started
November 2023
Primary completion
December 2029
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Antonio Curti, MD
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.